Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: An Integrated Post Hoc Analysis

INTRODUCTION: Assessing clinically important measures of disease progression is essential for evaluating therapeutic effects on disease stability in chronic obstructive pulmonary disease (COPD). This analysis assessed whether providing additional bronchodilation with the long-acting muscarinic antag...

Descripción completa

Detalles Bibliográficos
Autores principales: Naya, Ian P., Tombs, Lee, Lipson, David A., Compton, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182634/
https://www.ncbi.nlm.nih.gov/pubmed/30191464
http://dx.doi.org/10.1007/s12325-018-0771-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182634/
https://www.ncbi.nlm.nih.gov/pubmed/30191464
http://dx.doi.org/10.1007/s12325-018-0771-4

Ejemplares similares